- Home
- TARA vs NPV Comparison
TARA vs NPV Comparison
Compare TARA & NPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARA
- NPV
- Stock Information
- Founded
- TARA N/A
- NPV 1993
- Country
- TARA United States
- NPV United States
- Employees
- TARA N/A
- NPV N/A
- Industry
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- NPV Investment Managers
- Sector
- TARA Health Care
- NPV Finance
- Exchange
- TARA Nasdaq
- NPV Nasdaq
- Market Cap
- TARA 196.8M
- NPV 211.4M
- IPO Year
- TARA N/A
- NPV N/A
- Fundamental
- Price
- TARA $5.12
- NPV $11.47
- Analyst Decision
- TARA Strong Buy
- NPV
- Analyst Count
- TARA 6
- NPV 0
- Target Price
- TARA $19.80
- NPV N/A
- AVG Volume (30 Days)
- TARA 455.2K
- NPV 38.9K
- Earning Date
- TARA 11-03-2025
- NPV 01-01-0001
- Dividend Yield
- TARA N/A
- NPV 3.90%
- EPS Growth
- TARA N/A
- NPV N/A
- EPS
- TARA N/A
- NPV N/A
- Revenue
- TARA N/A
- NPV N/A
- Revenue This Year
- TARA N/A
- NPV N/A
- Revenue Next Year
- TARA N/A
- NPV N/A
- P/E Ratio
- TARA N/A
- NPV N/A
- Revenue Growth
- TARA N/A
- NPV N/A
- 52 Week Low
- TARA $2.21
- NPV $8.92
- 52 Week High
- TARA $10.48
- NPV $11.55
- Technical
- Relative Strength Index (RSI)
- TARA 56.48
- NPV 52.11
- Support Level
- TARA $4.96
- NPV $11.33
- Resistance Level
- TARA $5.39
- NPV $11.57
- Average True Range (ATR)
- TARA 0.30
- NPV 0.10
- MACD
- TARA -0.10
- NPV -0.01
- Stochastic Oscillator
- TARA 20.00
- NPV 56.36
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About NPV Nuveen Virginia Quality Municipal Income Fund
Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities. Company mostly invest in Education and Civic Organizations, Tax Obligation/General, Healthcare, Utilities , Housing/Multifamily, Transportation, and Others.